Patents Assigned to Axentis Pharma AG
  • Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface
    Publication number: 20100129343
    Abstract: The present invention is directed to the use of a compound stimulating deubiquitinating activity in a cell for the manufacture of a medicament for enhancing the expression of integral membrane proteins on the cell surface. Especially, the invention is directed to the use of such compound for the manufacture of a medicament for the treatment of a disease of condition selected from the group consisting of cystic fibrosis, diabetes insipidus, hypercholesterinaemia and long QT-syndrome-2.
    Type: Application
    Filed: January 27, 2010
    Publication date: May 27, 2010
    Applicant: Axentis Pharma AG
    Inventors: Michael Freissmuth, Tetyana Kirpenko, Christian Nanoff, Volodymyr M. Korkhov